| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41ca9b060cc324d126a65f7b6f529acc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2009-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69390939cbde2e4225d4b0f63bae3cd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8ccdb677dd4cb3cc059366113853f72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bcf0da106ce9f3a4715c5899884b7b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5171d57f7f9554cea7e87a806b59fb2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f54046f253f255d1f6dc8898f81fd839 |
| publicationDate |
2011-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2269586-A1 |
| titleOfInvention |
Pharmaceutical composition comprising desloratadine |
| abstract |
The present invention relates to a solid pharmaceutical composition comprising desloratadine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients and/or adjuvants including lactose, characterized in that a) desloratadine or the pharmaceutically acceptable salt thereof is present in a therapeutically effective amount and that b) the lactose is present as anhydrous lactose in an amount of 22 to 78 wt.-% based on the total weight of the solid pharmaceutical composition, uses and production processes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2568970-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2550958-C2 |
| priorityDate |
2009-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |